2021 American Transplant Congress » Kidney Living Donor: Long Term Outcomes
Date & Time:
None. Available on demand
Location: Virtual
Session Type: Poster Abstract
Meeting: 2021 American Transplant Congress
-
Awareness of Teratogenic Potential of Mycophenolic Acid Products and Pregnancy Outcomes in Kidney Transplant Recipients
-
Creatinine Reduction Ratio at 2 Postoperative Day as a Predicting Factor of Long-Term Outcomes After Living Donor Kidney Transplantation
-
Different Levels of GFR of Retained Kidney on the Long-term Safety of the Donors in Living-related Renal Transplantation
-
Factors Affecting Sensitization Following Kidney Allograft Failure
-
Frailty Component Trajectories Among Kidney Transplant Recipients
-
Impact of Rituximab Induction Therapy on Donor-specific Anti-HLA Antibodies in Abo-compatible Kidney Transplant Recipients
-
Patient Survival After Living Donor Kidney Donation
-
Pill Burden in Belatacept versus Tacrolimus-Based Immunosuppression
-
The Impact of Diabetes on Young Transplant Recipients: An American Perspective
-
Very Long-Term Patient and Kidney Allograft Outcomes in Kidney Transplant Recipients More Than 20 Years After Transplantation:
« View all sessions from the 2021 American Transplant Congress